Loading clinical trials...
Loading clinical trials...
Pharmacokinetic/Pharmacodynamic Aspects of Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs and Receiving Continuous Renal Replacement Therapy.
Conditions
Interventions
Colistin
Locations
1
Italy
Fondazione Policlinico A.Gemelli IRCSS
Roma, Italia, Italy
Start Date
July 14, 2021
Primary Completion Date
January 30, 2022
Completion Date
January 30, 2022
Last Updated
August 6, 2021
NCT07448805
NCT07222007
NCT07143695
NCT05108441
NCT07073508
NCT06557629
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions